| 1. |
- Sargeson, A. M., et al.
(författare)
-
Names and symbols for the transfermium elements
- 1997
-
Ingår i: Pure and Applied Chemistry. - : Walter de Gruyter GmbH. - 0033-4545 .- 1365-3075. ; 69:12, s. 2471-2473
-
Tidskriftsartikel (refereegranskat)abstract
- The recommendations (ref. 1) of the Commission on Nomenclature of Inorganic Chemistry (CNIC) on the nomenclature of the transfermium elements (101-109, inclusive) were considered by the IUPAC Bureau at Guildford (UK) in September 1995. As a result of the various criticisms of the recommendations and theway that they had been processed, the Bureau decided to adopt the recommendations as provisional and to circulate them to national/regional nomenclature centres in the normal way, with notices to be published innational/regional chemistry journals and magazines, requesting submission of comments to CNIC. In particular, the National Adhering Organizations (NAOs) were invited to express their views concerning the extant proposals for the names of these elements and the principles and traditions used to derive them. The response from the general chemical community was small, and the bulk of the replies came from nuclear scientists.
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
- Sargeson, A. M., et al.
(författare)
-
Names and symbols of transfermium elements (IUPAC recommendations 1994)
- 1994
-
Ingår i: Pure and Applied Chemistry. - : Walter de Gruyter GmbH. - 0033-4545 .- 1365-3075. ; 66:12, s. 2419-2421
-
Tidskriftsartikel (refereegranskat)abstract
- The Transfermium Working Group (TWG) was set up in 1986 under the joint auspices of the International Union of Pure and Applied Chemistry (IUPAC) and the International Union of Pure and Applied Physics (IUPAP). Its conclusions, duly endorsed by IUPAC and IUPAP, were published in the following three reports:1. Criteria that must be satisfied for the discovery of a new chemical element to be recognized, Pure & Appl. Chem., 63, 879-886 (1991).2. Discovery of the transfermium elements: Introduction to the discovery profiles, Pure & Appl. Chem., 65, 1757-1763 (1993).3, Discovery of the transfermium elements: Discovery profiles of the transfermium elements, Pure & Appl. Chem., 65, 1764-1814 (1993).IUPAC went a stage further by inviting responses on reports 2 and 3 from the three major groups concerned, i.e., Lawrence Berkeley Laboratory, California; Joint Institute for Nuclear Research, Dubna; and Gesellschaft fur Schwerionenforschung , Darmstadt. These responses together with the TWG's reply to the responses were published unedited in Pure & Appl. Chem.,Vol. 65, (1993), pp. 1815-1824.
|
|
| 5. |
- Andersson, C, et al.
(författare)
-
Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes
- 2013
-
Ingår i: Pediatric Diabetes. - : Wiley-Blackwell. - 1399-543X .- 1399-5448. ; 14:2, s. 97-105
-
Tidskriftsartikel (refereegranskat)abstract
- Andersson C, Vaziri-Sani F, Delli AJ, Lindblad B, Carlsson A, Forsander G, Ludvigsson J, Marcus C, Samuelsson U, Ivarsson SA, Lernmark A, Elding Larsson H, the BDD Study group. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes. Pediatric Diabetes 2013: 14: 97-105. Objective To establish the diagnostic sensitivity of and the relationships between autoantibodies to all three Zinc transporter 8 (Zinc transporter 8 autoantibody to either one, two, or all three amino acid variants at position 325, ZnT8A) variants to human leukocyte antigen (HLA)-DQ and to autoantibodies to glutamic acid decarboxylase (GADA), insulinoma-associated protein 2 (IA-2A), and insulin (IAA). Methods We analyzed 3165 patients with type 1 diabetes (T1D) in the Better Diabetes Diagnosis study for HLA-DQ genotypes and all six autoantibodies (ZnT8RA, arginine 325 Zinc transporter 8 autoantibody; ZnT8WA, tryptophan 325 Zinc transporter 8 autoantibody; ZnT8QA, glutamine 325 Zinc transporter 8 autoantibody; GADA, IA-2A, and IAA). Results ZnT8A was found in 65% of the patients and as many as 108 of 3165 (3.4%) had 13 ZnT8A alone. None had ZnT8QA alone. Together with GADA (56%), IA-2A (73%), and IAA (33%), 93% of the T1D patients were autoantibody positive. All three ZnT8A were less frequent in children below 2 yr of age (pandlt;0.0001). All three ZnT8A were associated with DQA1-B1*X-0604 (DQ6.4) and DQA1-B1*03-0302 (DQ8). ZnT8WA and ZnT8QA were negatively associated with DQA1-B1*05-02 (DQ2). Conclusions Analysis of ZnT8A increased the diagnostic sensitivity of islet autoantibodies for T1D as only 7% remained islet autoantibody negative. The association between DQ6.4 and all three ZnT8A may be related to ZnT8 antigen presentation by the DQ6.4 heterodimer.
|
|
| 6. |
|
|
| 7. |
|
|
| 8. |
- Elmroth, Sofi K.C., et al.
(författare)
-
Kinetics and Mechanism for Reaction between Ammine- and Haloamminegold(III) Complexes and Thiocyanate. Competitive Electron Transfer and Substitution
- 1989
-
Ingår i: Inorganic Chemistry. - : American Chemical Society (ACS). - 1520-510X .- 0020-1669. ; 28:14, s. 2703-2710
-
Tidskriftsartikel (refereegranskat)abstract
- The reactions in acidic aqueous solution between thiocyanate and each of the gold(III) complexes Au(NH3)43+, trans-Au(NH3)2C12+, and trans-Au(NH3)2Br2+ have been studied by use of potentiometric pH measurements and sequential-mixing stopped-flow spectrophotometry. The reactions give a common gold(I) product whereas the rate-controlling steps are different. The reaction between Au(NH3)43+ and thiocyanate takes place via rate-controlling substitution of an ammine ligand by thiocyanate with k = 7.6 +- 0.1 M-I s-l, DeltaHo = 61+- 1 kJ mol-I, and DeltaSo= 26+-3 J mo1-1 K-1 at 25.0 "C, followed by rapid reduction to gold(1) with the overall stoichiometry 3Au(NH3)43+ + 6SCN- + 4H+ + 4H20 = 2Au(SCN)2- + Au(SCN)(CN)- + S042- + 12NH4+ (i)For trans-Au(NH3)2X2+ (X = CI, Br), thiocyanate replaces halide in two rapid consecutive and reversible substitution steps without an observable solvent path prior to the slower reduction: trans-Au(NH3)2X2+ = Au(NH3)2XSCN+ = trans-Au(NH3)2(SCN)2+ (ii) Second-order rate constants (M-I s-I) at 2.0 oC are as follows: for X = CI; k1 = (9.0+-1.4) x I03, k-1 = (0.6+-0.2), k2 = (1.56+-0.21) X I05, k-2 = (3.4+-0.6) x 102; for X = Br, k1= (8.9+-0.3) x 104, k-1 = (1.32+-0.20) x 103, k2 = (1.4+-0.4) x 105, k-2 = (1.0+-0.7) x 104. Temperature variation of k, gave the following values: for X = CI; DeltaHo = 33+-7 kJ mol-', DeltaSo = -48+-21 J K-1 mol-1; for X = Br, DeltaHo = 30+-11 kJ mol-1, deltaSo = -50+-30 J K-1 mo1-1 at 25.0 oC. Parametrization of the substitution rate constants shows that the nature of the entering ligand is even more important than the trans effect for these complexes, in marked contrast to isoelectronic Pt(II) complexes. The relative stability constants for these short-lived complexes, K, = k,/k,, were obtained from the rate constants and are as follows: for X = CI, K1 = (1.5+-0.5) X 104, K2 = (4.6+-0.5) X 102; for X = Br, K1 = 67+-12, K2 = 12+-3. The ratio KI/K2 shows a nonstatistical distribution for the chloro-thiocyanato system, indicating a increased thermodynamic stability for the complex trans-Au(NH3)2CISCN+, whereas the bromo-thiocyanato system is approximately statistically distributed. An UV-vis spectrum for the intermediate short-lived complex trans-Au(NH3)2BrSCN+ was calculated from continuous-flow spectra. Reduction to gold(1) takes place via three parallel paths subsequent to establishment of the rapid substitution equilibria (ii). Each gold(III) complex trans-Au(NH3)2X(2-n)(SCN)n+ is reduced by outer-sphere thiocyanate in second-order reactions. The second-order rate constants, krn (n = 0, 1, 2), at 25.0 oC are as follows: for X = CI, kr1 = (2.7+-0.5) x 103, kr2 = (2.2+-0.4) x 102; for X = Br, kr0 = 10+-5, kr1 = (3.0+-0.5) x 102, kr2 = (2.5+-0.4) x 102 M-1 s-1, Temperature variation of kr2 gave DeltaHo = 66+-4 kJ mol-1 and DeltaSo = 21+-12 J mol-1 K-1 at 25.0 oC. The mixed chloro- and bromo-thiocyanato complexes are reduced most rapidly, indicating that an asymmetric distribution of electrons along the trans-axis facilitates reduction. It is concluded that reduction takes place by attack of outer-sphere thiocyanate on the sulfur of a coordinated thiocyanate. In keeping herewith, the two complexes trans-Au(NH3)2XSCN' (X = CI, Br), which contain a loosely bound halide ligand in the ground state, also substitute this halide ligand for thiocyanate most rapidly (k2). A unified mechanism for competitive electron transfer and ligand substitution for the reaction between gold(III) complexes and reducing ligands is suggested
|
|
| 9. |
- ERINGSMARK REGNÉLL, SIMON, et al.
(författare)
-
Pancreas volume and fat fraction in children with Type 1 diabetes
- 2016
-
Ingår i: Diabetic Medicine. - : Wiley. - 1464-5491 .- 0742-3071. ; 33:10, s. 1374-1379
-
Tidskriftsartikel (refereegranskat)abstract
- AIMS: People with Type 1 diabetes have smaller pancreases than healthy individuals. Several diseases causing pancreatic atrophy are associated with pancreatic steatosis, but pancreatic fat in Type 1 diabetes has not been measured. This cross-sectional study aimed to compare pancreas size and fat fraction in children with Type 1 diabetes and controls.METHODS: The volume and fat fraction of the pancreases of 22 children with Type 1 diabetes and 29 controls were determined using magnetic resonance imaging.RESULTS: Pancreas volume was 27% smaller in children with diabetes (median 34.9 cm(3) ) than in controls (47.8 cm(3) ; P < 0.001). Pancreas volume correlated positively with age in controls (P = 0.033), but not in children with diabetes (P = 0.649). Pancreas volume did not correlate with diabetes duration, but it did correlate positively with units of insulin/kg body weight/day (P = 0.048). A linear model of pancreas volume as influenced by age, body surface area and insulin units/kg body weight/day found that insulin dosage correlated with pancreas volume after controlling for both age and body surface area (P = 0.009). Pancreatic fat fraction was not significantly different between the two groups (1.34% vs. 1.57%; P = 0.891).CONCLUSIONS: Our findings do not indicate that pancreatic atrophy in Type 1 diabetes is associated with an increased pancreatic fat fraction, unlike some other diseases featuring reduced pancreatic volume. We speculate that our results may support the hypotheses that much of pancreatic atrophy in Type 1 diabetes occurs before the clinical onset of the disease and that exogenous insulin administration decelerates pancreatic atrophy after diabetes onset. This article is protected by copyright. All rights reserved.
|
|
| 10. |
- Hampe, C. S., et al.
(författare)
-
Reduced display of conformational epitopes in the N-terminal truncated GAD65 isoform : relevance for people with stiff person syndrome or DQ8/8-positive Type 1 diabetes mellitus
- 2019
-
Ingår i: Diabetic Medicine. - : Wiley-Blackwell. - 0742-3071 .- 1464-5491. ; 36:11, s. 1375-1383
-
Tidskriftsartikel (refereegranskat)abstract
- Aims: To investigate whether the N‐terminal truncated glutamic acid decarboxylase 65 (GAD65) isoform is as well recognized by people with stiff person syndrome as it is by people with Type 1 diabetes, and whether conformational GAD65 antibody epitopes are displayed properly by the isoform.Methods: GAD65 antibody‐positive healthy individuals (n=13), people with stiff‐person syndrome (n=15) and children with new‐onset Type 1 diabetes (n=654) were analysed to determine binding to full‐length GAD65 and the N‐terminal truncated GAD65 isoform in each of these settings. GAD65 autoantibody epitope specificity was correlated with binding ratios of full‐length GAD65/N‐terminal truncated GAD65.Results: The N‐terminal truncated GAD65 isoform was significantly less recognized in GAD65Ab‐positive people with stiff‐person syndrome (P=0.002) and in healthy individuals (P=0.0001) than in people with Type 1 diabetes. Moreover, at least two specific conformational GAD65Ab epitopes were not, or were only partially, presented by the N‐terminal truncated GAD65 isoform compared to full‐length GAD65. Finally, an N‐terminal conformational GAD65Ab epitope was significantly less recognized in DQ8/8 positive individuals with Type 1 diabetes (P=0.02).Conclusions: In people with stiff person syndrome preferred binding to the full‐length GAD65 isoform over the N‐terminal truncated molecule was observed. This binding characteristic is probably attributable to reduced presentation of two conformational epitopes by the N‐terminal truncated molecule. These findings support the notion of disease‐specific GAD65Ab epitope specificities and emphasize the need to evaluate the applicability of novel assays for different medical conditions.
|
|
